Understanding the effects of the first approved treatment for peanut allergies
Patient-Centered Outcomes of the First Approved Peanut Allergy Treatment
['FUNDING_OTHER'] · JOHNS HOPKINS UNIVERSITY · NIH-10991687
This study is looking at how Palforzia, the first FDA-approved treatment for peanut allergies, affects kids and their families, focusing on what they like and don’t like about the treatment and how it impacts their daily lives.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | JOHNS HOPKINS UNIVERSITY (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-10991687 on ClinicalTrials.gov |
What this research studies
This research investigates how the first FDA-approved treatment for peanut allergies, known as Palforzia, impacts patients and their families. It focuses on understanding the benefits and risks of this treatment from the perspective of children, adolescents, and their caregivers. By evaluating patient-centered outcomes, the research aims to gather insights on treatment preferences and the psychosocial effects of managing peanut allergies. Participants will be involved in assessing their experiences and perceptions regarding the therapy over time.
Who could benefit from this research
Good fit: Ideal candidates for this research include children and adolescents with peanut allergies, as well as their caregivers.
Not a fit: Patients without peanut allergies or those who are not affected by food allergies may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and better quality of life for patients with peanut allergies.
How similar studies have performed: Previous research has shown promising results in understanding patient-centered outcomes in allergy treatments, making this approach both relevant and potentially impactful.
Where this research is happening
BALTIMORE, UNITED STATES
- JOHNS HOPKINS UNIVERSITY — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DANTZER, JENNIFER ANNE — JOHNS HOPKINS UNIVERSITY
- Study coordinator: DANTZER, JENNIFER ANNE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.